PharmaEngine, Inc. (4162.TWO)
Key Executives
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Hong-Ren Wang Ph.D. | President & CEO | -- | -- | -- |
Jose Hsieh | Senior Manager of Accounting | -- | -- | -- |
Mr. Chi-Hsing Chang CPA | Vice President of Corporate Development | 4.02M | -- | -- |
Melody Lin | Director of Human Resources | -- | -- | -- |
PharmaEngine, Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 44
Description
PharmaEngine, Inc., a biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan. It offers ONIVYDE, a cancer medicine that blocks an enzyme called topoisomerase I, which is involved in copying cell DNA needed to make new cells. The company is developing PEP07, a CHK1 inhibitor, which is in Phase 1 clinical trial for the treatment of hematological tumors and solid tumors. PharmaEngine, Inc. was incorporated in 2002 and is headquartered in Taipei, Taiwan.
Corporate Governance
Upcoming Events
April 29, 2025 at 10:59 AM UTC
PharmaEngine, Inc. Earnings Date
Recent Events
August 12, 2024 at 12:00 AM UTC
Ex-Dividend Date